etacid 50 mcg/doză spray nazal, suspensie
world medicine ilac san.ve tic. a.Ș. - mometasonum - spray nazal, suspensie - 50 mcg/doză
nasacort 50 mcg/doză spray nazal, suspensie
gm pharmaceuticals ltd. - mometasonum - spray nazal, suspensie - 50 mcg/doză
ryaltris 600 mcg/25 mcg/doză spray nazal, suspensie
glenmark specialty s.a. - olopatadinum + mometasonum furoatum - spray nazal, suspensie - 600 mcg/25 mcg/doză
nasonex spray nazal, suspensie 50 mcg/doza
schering-plough central east ag - spray nazal, suspensie - 50 mcg/doza
posatex
intervet international bv - orbifloxacin, furoat de mometazonă, posaconazol - auriculare- - câini - tratamentul otitei externe acute și exacerbări acute ale otitei externe recurente, asociate cu bacterii sensibile la orbifloxacin și fungi sensibili la posaconazol, în special malassezia pachydermatis.
neptra
bayer animal health gmbh - florfenicol, clorhidrat de terbinafina, mometasone furoate - otologicals, corticosteroizi si antiinfectioase in combinatie - câini - pentru tratamentul acut canin otita externa sau exacerbări acute ale otitei recurente cauzate de infecții mixte de tulpini sensibile de bacterii sensibile la florfenicol (staphylococcus pseudintermedius) și fungi sensibili la terbinafina (malassezia pachydermatis).
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astm - medicamente pentru afecțiuni obstructive ale căilor respiratorii, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.